Biography

Luke is accredited by the European Patent Office (EPO) since 2012 and has extensive experience in drafting patent applications, building and managing international patent portfolios, EPO opposition and appeal proceedings, and preparing patentability and freedom-to-operate opinions.

Luke is active as a guest expert, lecturing on patent law and intellectual property as part of the GeneNovate Entrepreneurship Program for gene and cell therapy, and at the University of Potsdam in the field of Transfer and Innovation Management.

After studying at the University of Canterbury, New Zealand (Biochemistry/Genetics, BSc. Hons First Class) and research activity (Molecular Microbiology; AgResearch), Luke Buchanan earned a PhD (Epigenetics, Analytical Chemistry) at the Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG) and the Biotechnology Center of the Technical University of Dresden (BIOTEC-TUD).

Technical focus: Molecular diagnostics, antibodies/CARs, cell and gene therapy, gene editing, medicinal chemistry, pharmaceutical compounds and formulations, proteomics and genomics, analytical chemistry and computer-implemented processes in the biotech sector.

Recommendations

Dr. Luke Buchanan, "specializing in advising the biotechnology and biopharmaceutical industries, has a high level of scientific expertise and a very precise and thoughtful approach to his work (...)". - Legal 500

"Hertin Anwaltssozietät's 'dedicated and motivated' Berlin-based patent law team is highly specialized in life sciences, is also expanding into medical technology, and has niche expertise in protecting new therapeutic methods." - Legal 500